67 related articles for article (PubMed ID: 7986335)
21. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
[TBL] [Abstract][Full Text] [Related]
22. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
23. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
[TBL] [Abstract][Full Text] [Related]
24. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients.
Frydecka I; Mazur G
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):127-30. PubMed ID: 8915517
[TBL] [Abstract][Full Text] [Related]
25. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
[TBL] [Abstract][Full Text] [Related]
26. Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.
Romano MF; Turco MC; Stanziola A; Giarrusso PC; Petrella A; Tassone P; van Lier R; Venuta S; Formisano S
Cell Immunol; 1993 May; 148(2):455-63. PubMed ID: 8098674
[TBL] [Abstract][Full Text] [Related]
27. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
Siefken R; Kurrle R; Schwinzer R
Cell Immunol; 1997 Feb; 176(1):59-65. PubMed ID: 9070318
[TBL] [Abstract][Full Text] [Related]
28. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
[TBL] [Abstract][Full Text] [Related]
29. Impaired T cell proliferation in acute dengue infection.
Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
[TBL] [Abstract][Full Text] [Related]
30. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
[TBL] [Abstract][Full Text] [Related]
31. Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production.
Sunder-Plassmann R; Pickl WF; Majdic O; Knapp W; Holter W
Cell Immunol; 1995 Aug; 164(1):20-7. PubMed ID: 7634349
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
[TBL] [Abstract][Full Text] [Related]
33. [Anti-CD28 antibody costimulation enhances anti-CD3 antibody activating T cells and lowering TGF-beta expression in vitro].
Lou Q; Lü M; Yu M; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):547-51. PubMed ID: 16800940
[TBL] [Abstract][Full Text] [Related]
34. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency.
Lin SJ; Chao HC; Chang KW; Yan DC
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):65-70. PubMed ID: 12877452
[TBL] [Abstract][Full Text] [Related]
35. Functional evaluation of proliferative T cell responses in patients with severe T lymphopenia: characterization of optimal culture conditions and standardized activation signals for a simple whole blood assay.
Wendelbo Ø; Bruserud Ø
J Hematother Stem Cell Res; 2003 Oct; 12(5):525-35. PubMed ID: 14594509
[TBL] [Abstract][Full Text] [Related]
36. Evidence for intact CD28 signaling in T cell hyporesponsiveness induced by the HIV-1 nef gene.
Collette Y; Mawas C; Olive D
Eur J Immunol; 1996 Aug; 26(8):1788-93. PubMed ID: 8765022
[TBL] [Abstract][Full Text] [Related]
37. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
38. Regulation of interleukin-4 production in human mononuclear cells.
Holter W; Majdic O; Kalthoff FS; Knapp W
Eur J Immunol; 1992 Oct; 22(10):2765-7. PubMed ID: 1356786
[TBL] [Abstract][Full Text] [Related]
39. Co-expression of IL-12 receptors along with CXCR3 and CD25 on activated peripheral blood T lymphocytes.
Reddy M; Wong J; Davis C; Prabhakar U
Cell Immunol; 2005; 236(1-2):123-30. PubMed ID: 16165111
[TBL] [Abstract][Full Text] [Related]
40. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
